SAI - Detailed view

PAXLOVID Filmtabl 4x150mg/2x100mg 5 x 6 Stk

Drug

Name

Paxlovid, Filmtabletten

Field of application

Behandlung von COVID-19

ATC

J05 - ANTIVIRALS FOR SYSTEMIC USE

08.03.0. – antivirals

Use

HAM – Human medicine

pharmaceutical form

FILM – Film-coated tablet

Remedy code

S – synthetic products for human use

Dispensing categories

A – Dispensed once only on prescription by a physician or veterinarian (A)

Authorisation status

B – limited

Authorisation number

68793

Initial registration date

6/15/2022

Expiry date

6/15/2024

Dosage strength

Name

Paxlovid, Filmtabletten

Field of application

Behandlung von COVID-19

Dosage strength number

Authorisation status

B – limited

Package

GTIN**

7680687930017

Trade status*

No information made available

Status

A/R – Authorised / referenced

Package size

noch nicht def.

Package code

001

Authorisation status

B – limited

Declaration

Component A)

Active substance

150 mg PF-07321332

Excipient

cellulosum microcristallinum
185 mg lactosum monohydricum
carmellosum natricum conexum
silica colloidalis anhydrica
natrii stearylis fumaras
hypromellosum
E 171
macrogolum 400
E 172 (rubrum)
0.99 mg natrium

Component B)

Active substance

100 mg ritonavirum

Excipient

copovidonum
silica colloidalis anhydrica
sorbitani lauras
calcii hydrogenophosphas
natrii stearylis fumaras
hypromellosum
E 171
macrogolum 400
macrogolum 3350
hydroxypropylcellulosum
talcum
silica colloidalis anhydrica
polysorbatum 80
0.388 mg natrium

Authorisation holder

GLN**

7601001010604

Address

Pfizer AG
Schärenmoosstrasse 99
8052 Zürich (ZH)

Date of revision of the text

7/26/2022

Information for prof.

Leaflet

Report error

Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.